Given FBL’s role in ribosome biogenesis, oncogenic signaling, and 2′-O-methylation (Nm)–mediated regulation of the PI3K/AKT/mTOR pathway (33), we hypothesized that the NOP56–FBL axis may drive HCC progression via this signaling cascade. The gene discussed is FBL; the disease is hepatocellular carcinoma.